Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth
  2. Wolfe, Andrew L; Zhou, Qingwen; Toska, Eneda; Galeas, Jacqueline; Ku, Angel A; Koche, Richard P; Bandyopadhyay, Sourav; Scaltriti, Maurizio; Lebrilla, Carlito B; McCormick, Frank; Kim, Sung Eun
  3. Proceedings of the National Academy of Sciences of the United States of America. 2021, Aug 03; 118(31):
  1. 2.   Crystal structure of UDP-glucose pyrophosphorylase from Yersinia pestis, a potential therapeutic target against plague
  2. Gibbs, Morgan E; Lountos,George; Gumpena, Rajesh; Waugh,David
  3. Acta crystallographica. Section F, Structural biology communications. 2019, Sep 01; 75(Pt 9): 608-615.
  1. 3.   Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer
  2. Tang, W.; Fu, Y. P.; Figueroa, J. D.; Malats, N.; Garcia-Closas, M.; Chatterjee, N.; Kogevinas, M.; Baris, D.; Thun, M.; Hall, J. L.; De Vivo, I.; Albanes, D.; Porter-Gill, P.; Purdue, M. P.; Burdett, L.; Liu, L. Y.; Hutchinson, A.; Myers, T.; Tardon, A.; Serra, C.; Carrato, A.; Garcia-Closas, R.; Lloreta, J.; Johnson, A.; Schwenn, M.; Karagas, M. R.; Schned, A.; Black, A.; Jacobs, E. J.; Diver, W. R.; Gapstur, S. M.; Virtamo, J.; Hunter, D. J.; Fraumeni, J. F.; Chanock, S. J.; Silverman, D. T.; Rothman, N.; Prokunina-Olsson, L.
  3. Human Molecular Genetics. 2012, Apr; 21(8): 1918-1930.
  1. 4.   The N-acetyl-binding pocket of N-acetylglucosaminyltransferases also accommodates a sugar analog with a chemical handle at C2
  2. Pasek, M.; Ramakrishnan, B.; Boeggeman, E.; Mercer, N.; Dulcey, A. E.; Griffiths, G. L.; Qasba, P. K.
  3. Glycobiology. 2012, Mar; 22(3): 379-388.
  1. 5.   A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
  2. Rothman, N.; Garcia-Closas, M.; Chatterjee, N.; Malats, N.; Wu, X. F.; Figueroa, J. D.; Real, F. X.; Van den Berg, D.; Matullo, G.; Baris, D.; Thun, M.; Kiemeney, L. A.; Vineis, P.; De Vivo, I.; Albanes, D.; Purdue, M. P.; Rafnar, T.; Hildebrandt, M. A. T.; Kiltie, A. E.; Cussenot, O.; Golka, K.; Kumar, R.; Taylor, J. A.; Mayordomo, J. I.; Jacobs, K. B.; Kogevinas, M.; Hutchinson, A.; Wang, Z. W.; Fu, Y. P.; Prokunina-Olsson, L.; Burdett, L.; Yeager, M.; Wheeler, W.; Tardon, A.; Serra, C.; Carrato, A.; Garcia-Closas, R.; Lloreta, J.; Johnson, A.; Schwenn, M.; Karagas, M. R.; Schned, A.; Andriole, G.; Grubb, R.; Black, A.; Jacobs, E. J.; Diver, W. R.; Gapstur, S. M.; Weinstein, S. J.; Virtamo, J.; Cortessis, V. K.; Gago-Dominguez, M.; Pike, M. C.; Stern, M. C.; Yuan, J. M.; Hunter, D. J.; McGrath, M.; Dinney, C. P.; Czerniak, B.; Chen, M.; Yang, H. S.; Vermeulen, S. H.; Aben, K. K.; Witjes, J. A.; Makkinje, R. R.; Sulem, P.; Besenbacher, S.; Stefansson, K.; Riboli, E.; Brennan, P.; Panico, S.; Navarro, C.; Allen, N. E.; Bueno-De-Mesquita, H. B.; Trichopoulos, D.; Caporaso, N.; Landi, M. T.; Canzian, F.; Ljungberg, B.; Tjonnel, A.; Clavel-Chapelon, F.; Bishop, D. T.; Teo, M. T. W.; Knowles, M. A.; Guarrera, S.; Polidoro, S.; Ricceri, F.; Sacerdote, C.; Allione, A.; Cancel-Tassin, G.; Selinski, S.; Hengstler, J. G.; Dietrich, H.; Fletcher, T.; Rudnai, P.; Gurzau, E.; Koppova, K.; Bolick, S. C. E.; Godfrey, A.; Xu, Z. L.; Sanz-Velez, J. I.; Garcia-Prats, M. D.; Sanchez, M.; Valdivia, G.; Porru, S.; Benhamou, S.; Hoover, R. N.; Fraumeni, J. F.; Silverman, D. T.; Chanock, S. J.
  3. Nature Genetics. 2010, Nov; 42(11): 978-U98.
  1. 7.   Deoxygenated Disaccharide Analogs as Specific Inhibitors of beta 1-4-Galactosyltransferase 1 and Selectin-mediated Tumor Metastasis
  2. Brown, J. R.; Yang, F.; Sinha, A.; Ramakrishnan, B.; Tor, Y.; Qasba, P. K.; Esko, J. D.
  3. Journal of Biological Chemistry. 2009 284(8): 4952-4959.
  1. 8.   Multiple Site-Specific in Vitro Labeling of Single-Chain Antibody
  2. Ramakrishnan, B.; Boeggeman, E.; Manzoni, M.; Zhu, Z. Y.; Loomis, K.; Puri, A.; Dimitrov, D. S.; Qasba, P. K.
  3. Bioconjugate Chemistry. 2009 20(7): 1383-1389.
  1. 9.   Pharmacokinetics, pharmacodynamics and drug metabolism - Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol
  2. Lakhani, N. J.; Sparreboom, A.; Xu, X.; Veenstra, T. D.; Venitz, J.; Dahut, W. L.; Figg, W. D.
  3. Journal of Pharmaceutical Sciences. 2007, Jul; 96(7): 1821-1831.
  1. 10.   Oligosaccharide preferences of beta 1,4-galactosyltransferase-I: Crystal structures of Met340His mutant of human beta 1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Ratner, D. M.; Seeberger, P. H.; Qasba, P. K.
  3. Journal of Molecular Biology. 2005, OCT 14; 353(1): 53-67.
  1. 11.   Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I
  2. Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Biochemistry. 2005, MAR 8; 44(9): 3202-3210.
  1. 13.   Structure and catalytic cycle of beta-1,4-galactosyltransferase
  2. Ramakrishnan, B.; Boeggeman, E.; Ramasamy, V.; Qasba, P. K.
  3. Current Opinion in Structural Biology. 2004, OCT; 14(5): 593-600.
  1. 14.   2-substitution of adenine nucleotide analogues containing a bicyclo 3.1.0 hexane ring system locked in a northern conformation: Enhanced potency as P2Y(1) receptor antagonists
  2. Kim, H. S.; Ohno, M.; Xu, B.; Kim, H. O.; Choi, Y. S.; Ji, X. D.; Maddileti, S.; Marquez, V. E.; Harden, T. K.; Jacobson, K. A.
  3. Journal of Medicinal Chemistry. 2003 46(23): 4974-4987.
  1. 15.   Clinical pharmacology of flavopiridol following a 72-hour continuous infusion
  2. Rudek, M. A.; Bauer, K. S.; Lush, R. M.; Stinson, S. F.; Senderowicz, A. M.; Headlee, D. J.; Arbuck, S. G.; Cox, M. C.; Murgo, A. J.; Sausville, E. A.; Figg, W. D.
  3. Annals of Pharmacotherapy. 2003 37(10): 1369-1374.
  1. 16.   The role of tryptophan 314 in the conformational changes of beta 1,4-galactosyltransferase-I
  2. Ramasamy, V.; Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Journal of Molecular Biology. 2003 331(5): 1065-1076.
  1. 17.   Studies on the metal binding sites in the catalytic domain of beta 1,4-galactosyltransferase
  2. Boeggeman, E.; Qasba, P. K.
  3. Glycobiology. 2002 12(7): 395-407.
  1. 18.   beta-1,4-galactosyltransferase and lactose synthase: Molecular mechanical devices
  2. Ramakrishnan, B.; Boeggeman, E.; Qasba, P. K.
  3. Biochemical and Biophysical Research Communications. 2002 291(5): 1113-1118.
  1. 19.   Crystal structure of beta 1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site
  2. Ramakrishnan, B.; Balaji, P. V.; Qasba, P. K.
  3. Journal of Molecular Biology. 2002 318(2): 491-502.
  1. 20.   Crystal structure of RNA 3 '-terminal phosphate cyclase, a ubiquitous enzyme with unusual topology
  2. Palm, G. J.; Billy, E.; Filipowicz, W.; Wlodawer, A.
  3. Structure with Folding & Design. 2000 8(1): 13-23.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel